Maintenance therapies in bipolar disorder: focus on randomized controlled trials.
OBJECTIVE: Lithium remains the cornerstone of maintenance therapy for bipolar disorder despite growing use of other agents, including divalproex, lamotrigine, carbamazepine and the atypical antipsychotics. Lithium has the largest body of data to support its continued use as a prophylactic agent; how...
| Publicado en: | Australian & New Zealand Journal of Psychiatry Vol. 39; no. 8; pp. 652 - 662 |
|---|---|
| Autores principales: | , |
| Formato: | research systematic review tables/charts Journal Article |
| Publicado: |
Sage Publications Inc.
Aug2005
|
| Acceso en línea: | Ver este registro en EBSCOhost |